tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SOLTF Stock Latest News

Nxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
Company AnnouncementsNxera Pharma Plans Capital Reserve Reduction for Shareholder Flexibility
1d ago
Nxera Pharma Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Nxera Pharma Reports Strong Revenue Growth in 2024
7d ago
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
PremiumCompany Announcements
Nxera Pharma Proposes Amendments to Enable Virtual-Only Shareholder Meetings
8d ago
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
PremiumCompany Announcements
Nxera Pharma Announces Board Changes to Enhance Strategic Oversight
8d ago
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
PremiumCompany Announcements
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
8d ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsSOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10d ago
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
Premium
Company Announcements
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
3M ago
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
Premium
Company Announcements
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
3M ago
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
PremiumCompany Announcements
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
4M ago
Nxera Pharma Reports Increased Revenue but Continues to Face Losses
PremiumCompany Announcements
Nxera Pharma Reports Increased Revenue but Continues to Face Losses
4M ago
Nxera Pharma Reports Key Milestones and Revenue Growth
PremiumCompany Announcements
Nxera Pharma Reports Key Milestones and Revenue Growth
4M ago
SOLTF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SOLTF Upcoming Earnings Report: What to Expect?
4M ago
Nxera Pharma Partners with Shionogi on Insomnia Drug
PremiumCompany AnnouncementsNxera Pharma Partners with Shionogi on Insomnia Drug
5M ago
Nxera Pharma Secures $35M After Trial Success
Premium
Company Announcements
Nxera Pharma Secures $35M After Trial Success
6M ago
Nxera Pharma Advances Schizophrenia Treatment
Premium
Company Announcements
Nxera Pharma Advances Schizophrenia Treatment
6M ago
Nxera notes Phase 2 data for partnered schizophrenia candidate NBI-1117568
PremiumThe Fly
Nxera notes Phase 2 data for partnered schizophrenia candidate NBI-1117568
6M ago
NBIX
Nxera Pharma Posts Revenue Surge Amid Net Loss
PremiumCompany Announcements
Nxera Pharma Posts Revenue Surge Amid Net Loss
7M ago
Nxera Pharma Shows Robust Q2 Growth and Progress
PremiumCompany Announcements
Nxera Pharma Shows Robust Q2 Growth and Progress
7M ago
SOLTF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SOLTF Earnings this Week: How Will it Perform?
7M ago
Nxera Pharma Hits Milestone with AbbVie Partnership
PremiumCompany AnnouncementsNxera Pharma Hits Milestone with AbbVie Partnership
8M ago
Sosei Group upgraded to Buy from Hold at Jefferies
Premium
The Fly
Sosei Group upgraded to Buy from Hold at Jefferies
1y ago
Sosei Group downgraded to Hold from Buy at Jefferies
Premium
The Fly
Sosei Group downgraded to Hold from Buy at Jefferies
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >